Related Experiment Video
Updated: Jan 6, 2026
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
Published on: August 2, 2022
Nanoparticles Targeting STATs in Cancer Therapy
Milad Ashrafizadeh1, Zahra Ahmadi2, Niranjan G Kotla3
1Department of Basic Science, Faculty of Veterinary Medicine, University of Tabriz, Tabriz 5166616471, Iran. dvm.milad73@yahoo.com.
Abstract:
Over the past decades, an increase in the incidence rate of cancer has been witnessed. Although many efforts have been made to manage and treat this life threatening condition, it is still one of the leading causes of death worldwide. Therefore, scientists have attempted to target molecular signaling pathways involved in cancer initiation and metastasis. It has been shown that signal transducers and activator of transcription (STAT) contributes to the progression of cancer cells. This important signaling pathway is associated with a number of biological processes including cell cycle, differentiation, proliferation and apoptosis. It appears that dysregulation of the STAT signaling pathway promotes the migration, viability and malignancy of various tumor cells. Hence, there have been many attempts to target the STAT signaling pathway. However, it seems that currently applied therapeutics may not be able to effectively modulate the STAT signaling pathway and suffer from a variety of drawbacks such as low bioavailability and lack of specific tumor targeting. In the present review, we demonstrate how nanocarriers can be successfully applied for encapsulation of STAT modulators in cancer therapy.
Insights
Nanocarriers can encapsulate signal transducers and activators of transcription (STAT) modulators to improve cancer therapy by overcoming limitations of current treatments. This approach enhances tumor targeting and bioavailability for more effective cancer management.
Area of Science:
- Oncology
- Nanotechnology
- Molecular Biology
Background:
- Cancer incidence is rising globally, remaining a leading cause of death.
- Signal transducers and activators of transcription (STAT) pathways are implicated in cancer initiation, metastasis, and progression.
- Current therapeutics targeting STAT pathways have limitations, including poor bioavailability and lack of tumor specificity.
Purpose of the Study:
- To review the application of nanocarriers for STAT modulator delivery in cancer therapy.
- To highlight how nanocarriers can overcome existing therapeutic challenges.
Main Methods:
- Literature review focusing on nanocarrier-based drug delivery systems.
- Analysis of STAT signaling pathways in cancer.
- Evaluation of nanocarrier encapsulation strategies for STAT modulators.
Main Results:
- Nanocarriers offer a promising platform for encapsulating STAT modulators.
- Encapsulation can improve drug bioavailability and tumor-specific targeting.
- This strategy addresses limitations of conventional STAT-targeting cancer therapies.
Conclusions:
- Nanocarrier-mediated delivery of STAT modulators represents a significant advancement in cancer therapy.
- This approach holds potential for more effective and targeted cancer treatment by modulating critical signaling pathways.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:15Drugs that Stabilize Microtubules
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...